Industrial microwave drying of yellow mealworm larvae (Tenebrio molitor): impact on moisture content, water activity and microbial load

status: publishe

Marination of yellow mealworm larvae (Tenebrio molitor) in soy sauce and wine to improve shelf life

status: publishe

Processing of mealworms into paste at pilot scale and fermentation of the paste at laboratory scale

status: publishe

Suitability of microwave drying for mealworms (Tenebrio molitor) as alternative to freeze drying: impact on nutritional quality and colour

Freeze drying represents the current practice to stabilize mealworms, even though it is an energy demanding technique. Therefore, it was examined in the present study whether microwave drying could be a proper alternative. To this end, the impact of both drying techniques on the proximate composition, vitamin B12 content, fatty acid profile, oxidation status and colour parameters of mealworms was investigated. Furthermore, the influence of the application of vacuum during microwave drying was studied. The different drying technologies resulted in small differences in the proximate composition, while the vitamin B12 content was only reduced by microwave drying. The fat fraction of freeze dried mealworms showed a higher oxidation status than the fat of microwave dried mealworms. Application of a vacuum during the microwave drying process did not appear to offer advantages. This research shows that for mealworms microwave drying can be a proper alternative to freeze drying.status: publishe

Stability assessment and laboratory scale fermentation of pastes produced on a pilot scale from mealworms (Tenebrio molitor)

European consumers generally still have a reluctant attitude towards the consumption of insects. One strategy to trigger the willingness to consume edible insects is to process them invisibly in familiar foodstuffs. To facilitate this, insects need to be processed to intermediates that can be incorporated readily in products by the food industry. To this end, a mealworm paste that was free of tastable exoskeleton particles was manufactured successfully using industrial equipment. Of this novel intermediate the proximate and fatty acid composition, moisture content, water activity, pH, viscosity, peroxide and p-anisidine values and colour was analysed. Next, the impact of storage temperature (4 °C and −21 °C) and presence of preservatives (sodium nitrite and sodium lactate) on the chemical and microbial stability of the paste were evaluated, as well as its fermentability to assess the most suited preservation strategy. During storage at −21 °C, all tested parameters remained constant for three months, except for some fat oxidation. At 4 °C, substantial microbial growth was observed during three weeks of storage, regardless of the use of preservatives. Finally, the paste was also shown to be suited for fermentation. Future research should assess whether fermentation can extend the storage time and/or improve the product quality.status: publishe

Innovative processing technologies for mealworm larvae (Tenebrio molitor): Microwave drying and high moisture extrusion

status: publishe

A novel, multi-active emollient for the prevention of acute radiation dermatitis in breast cancer patients:a randomized clinical trial

Purpose: To investigate the efficacy of a novel, multi-active emollient in preventing and managing acute radiation dermatitis (ARD) in breast cancer patients undergoing moderate hypofractionated (HF) radiotherapy (RT) compared to standard of care. Methodsa: A monocentric, open-label, randomized clinical trial (RCT) with breast cancer patients receiving moderate HF (dose: 40.05–55.86 Gy, fractions: 15–21) was conducted between January 2022 and May 2023. The experimental group received the novel emollient, while the control group received the standard skin care. Patients applied the skin care products twice daily during the complete RT course. The primary outcome was the severity of ARD at the final RT session measured by the modified Radiation Therapy Oncology Group (RTOG) criteria. Secondary outcomes included patient symptoms, quality of life (QoL), and treatment satisfaction. Results: A total of 100 patients with 50 patients per group were enrolled. In the control group, 50% of the patients developed RTOG grade 1 ARD and 48% grade 2 or higher, while in the experimental group, the severity of ARD was significantly lower with 82% grade 1 and 16% grade 2 ARD (P =.013, ? 2-test). The frequency and severity of xerosis were significantly lower in the experimental compared to the control group (Ps =.036, Mann Whiney U test). The impact of ARD on the QoL was low, and treatment satisfaction was high in both groups, with no significant difference. Conclusion: This RCT shows that the novel, multi-active emollient significantly reduced the ARD RTOG grade. Research in a more diverse patient population is warranted. Trial registration: ClinicalTrials.gov: NCT04929808 (11/06/2021)

Oxygen targets and 6-month outcome after out of hospital cardiac arrest: a pre-planned sub-analysis of the targeted hypothermia versus targeted normothermia after Out-of-Hospital Cardiac Arrest (TTM2) trial

International audienceAbstract Background Optimal oxygen targets in patients resuscitated after cardiac arrest are uncertain. The primary aim of this study was to describe the values of partial pressure of oxygen values (PaO 2 ) and the episodes of hypoxemia and hyperoxemia occurring within the first 72 h of mechanical ventilation in out of hospital cardiac arrest (OHCA) patients. The secondary aim was to evaluate the association of PaO 2 with patients’ outcome. Methods Preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after OHCA (TTM2) trial. Arterial blood gases values were collected from randomization every 4 h for the first 32 h, and then, every 8 h until day 3. Hypoxemia was defined as PaO 2  300 mmHg. Mortality and poor neurological outcome (defined according to modified Rankin scale) were collected at 6 months. Results 1418 patients were included in the analysis. The mean age was 64 ± 14 years, and 292 patients (20.6%) were female. 24.9% of patients had at least one episode of hypoxemia, and 7.6% of patients had at least one episode of severe hyperoxemia. Both hypoxemia and hyperoxemia were independently associated with 6-month mortality, but not with poor neurological outcome. The best cutoff point associated with 6-month mortality for hypoxemia was 69 mmHg (Risk Ratio, RR = 1.009, 95% CI 0.93–1.09), and for hyperoxemia was 195 mmHg (RR = 1.006, 95% CI 0.95–1.06). The time exposure, i.e., the area under the curve (PaO 2 -AUC), for hyperoxemia was significantly associated with mortality ( p = 0.003). Conclusions In OHCA patients, both hypoxemia and hyperoxemia are associated with 6-months mortality, with an effect mediated by the timing exposure to high values of oxygen. Precise titration of oxygen levels should be considered in this group of patients. Trial registration : clinicaltrials.gov NCT02908308 , Registered September 20, 2016

Ventilatory settings in the initial 72 h and their association with outcome in out-of-hospital cardiac arrest patients: a preplanned secondary analysis of the targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (TTM2) trial

International audienc